Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 701 (USA) (Dr. Reyes)
· consented 2014-01-25
Adverse events
5
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild APPLICATION SITE ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-03-09 (study day 44.0); relationship: PROBABLE
mild
assessed
2026-08-18
Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-02-22 (study day 29.0); relationship: POSSIBLE
mild
assessed
2026-08-18
Mild RHINORRHOEA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-07-09 (study day 166.0); relationship: NONE
mild
assessed
2026-08-18
Mild RHINORRHOEA — outcome: RECOVERED/RESOLVED; onset 2014-07-09 (study day 166.0); relationship: NONE
mild
assessed
2026-08-18
Mild SALIVARY HYPERSECRETION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-26 (study day 2.0); relationship: NONE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.